Canada · Health Canada Drug Product Database

TAMIFLU ORAL SUSPENSION

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
69640
DIN
02245549
Form
Powder For Suspension
Company as listed by source
HOFFMANN-LA ROCHE LIMITED
Source status
Cancelled Post Market (2013-12-12)
Source last updated
2026-06-17

Source-listed ingredients

  • OSELTAMIVIR (OSELTAMIVIR PHOSPHATE) — 12 MG — per 1 ML

These values do not establish equivalence or a dose recommendation.

Packages

  • 75ml

Source and coverage

Open Health Canada Drug Product Database →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse Canada records →
TAMIFLU ORAL SUSPENSION — Canada | Molindra Medicines